PT Charlie Hospital Semarang Tbk (IDX:RSCH)
248.00
0.00 (0.00%)
At close: Nov 20, 2026
IDX:RSCH Revenue
PT Charlie Hospital Semarang Tbk had revenue of 18.44B IDR in the quarter ending September 30, 2026, a decrease of -2.54%. This brings the company's total for the last twelve months to 118.98B, up 102.23% year-over-year. In the year 2025, PT Charlie Hospital Semarang Tbk had annual revenue of 114.40B with 135.86% growth. That makes PT Charlie Hospital Semarang Tbk the 39,112th largest company in the world by revenue and 722nd in Indonesia.
Revenue (ttm)
118.98B
Revenue Growth
+102.23%
P/S Ratio
5.52
Revenue / Employee
569.29M
Employees
209
Market Cap
657.20B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 114.40B | 65.89B | 135.86% |
| Dec 31, 2024 | 48.50B | 6.34B | 15.04% |
| Dec 31, 2023 | 42.16B | 9.13B | 27.63% |
| Dec 31, 2022 | 33.03B | -2.52B | -7.10% |
| Dec 31, 2021 | 35.56B | 22.29B | 168.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| PT Lippo Karawaci Tbk | 7.73T |
| PT Medikaloka Hermina Tbk | 7.37T |
| PT Famon Awal Bros Sedaya Tbk | 2.77T |
| PT Sarana Meditama Metropolitan Tbk | 2.03T |
| PT Bundamedik Tbk | 1.65T |
| PT Murni Sadar Tbk | 1.57T |
| PT Nitrasanata Dharma | 942.27B |
| PT Metro Healthcare Indonesia Tbk | 571.05B |